Does Iowa Medicaid cover Ozempic or Wegovy or Rybelsus for weight loss?

Other indications only. Wegovy is preferred on the PDL, but the weight-loss indication is not covered. Prior authorization is for cardiovascular risk and MASH only

Does Iowa Medicaid cover Mounjaro or Zepbound for weight loss?

Other indications only. Zepbound is preferred on the PDL, but the weight-loss indication is not covered. Prior authorization is for obstructive sleep apnea only

Medicaid coverage

Iowa: what Medicaid covers

Iowa’s July 1, 2026 preferred drug list names Wegovy and Zepbound as preferred products, but its comment legend says the weight-loss indication is not covered and its prior authorization criteria say payment for excluded medical uses such as weight loss will be denied. Wegovy can be approved for cardiovascular risk and MASH, and Zepbound for obstructive sleep apnea. Saxenda is not named in either document.

Checked against the primary source August 27, 2026

What Medicaid in Iowa covers, and the criteria that apply.
Drug	Position	Criteria
Semaglutide	Other indications only	Wegovy is preferred on the PDL, but the weight-loss indication is not covered. Prior authorization is for cardiovascular risk and MASH only Changed July 1, 2026
Tirzepatide	Other indications only	Zepbound is preferred on the PDL, but the weight-loss indication is not covered. Prior authorization is for obstructive sleep apnea only Changed July 1, 2026
Liraglutide	not checked	Saxenda is not named on the PDL or the prior authorization criteria

Semaglutide Other indications only

Wegovy is preferred on the PDL, but the weight-loss indication is not covered. Prior authorization is for cardiovascular risk and MASH only

Changed July 1, 2026
Tirzepatide Other indications only

Zepbound is preferred on the PDL, but the weight-loss indication is not covered. Prior authorization is for obstructive sleep apnea only

Changed July 1, 2026
Liraglutide not checked

Saxenda is not named on the PDL or the prior authorization criteria

If the answer is no. Around 45% of initial prior authorizations for these drugs are refused, and 35 to 45% of first-level appeals are overturned. A refusal is not the end of the process, and the cash-pay routes are priced on this site alongside it.

Sources

Every claim above is checked against the primary text, and the date is the day we last opened it.

1
Iowa Medicaid Preferred Drug List, Effective July 1, 2026
Iowa Department of Health and Human Services, Iowa Medicaid Primary text read and checked Checked August 27, 2026